Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00996190Phase 4Completed
Phase 4, randomised, double-blind trial of phenylephrine in hypotension (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: The maximum decrease in cardiac output in the pre-delivery period at 30 minutes. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00996190.